☰

Pomila Singh

Affiliations: 
University of Texas Medical Branch, Galveston, TX 
Area:
Cell Biology, Molecular Biology, Oncology
Google:
"Pomila Singh"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Stephanie L. Cobb grad student 2003 UTMB
Carla Kantara grad student 2012 UTMB

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Park SY, Kim JY, Choi JH, et al. (2018) Inhibition of LEF1-mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Sarkar S, O'Connell MR, Okugawa Y, et al. (2017) FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer. Molecular Cancer Research : McR
Sarkar S, Popov VL, O'Connell MR, et al. (2017) A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy. Laboratory Investigation; a Journal of Technical Methods and Pathology
Connell MO, Sarkar S, Spratt H, et al. (2017) Abstract 902: Cancer-stem-cell (CSC) marker, DCLK1-S, enhances invasive potential of cancer cells by phosphorylating/activating NFATc2: role of COL3A1 and SPARC in mediating metastatic effects of DCLK1-S/NFATc2 Cancer Research. 77: 902-902
Sarkar S, Popov VLL, O'Connell M, et al. (2017) Abstract 729: A novel cancer-stem-cell biomarker, DCLK1-S, traffics to nuclei of colon cancer cells: potential use as a biomarker for assessing colon cancer risk after screening colonoscopy Cancer Research. 77: 729-729
Singh P, O'Connell M, Shubhashish S. (2016) Epigenetic regulation of human DCLK-1 gene during colon-carcinogenesis: clinical and mechanistic implications. Stem Cell Investigation. 3: 51
Sarkar S, Connell MO, Singh P. (2016) Abstract 5242: Differential, dose-dependent, effects of curcumin/analogs, on long (L) versus short (S) isoforms of a cancer stem cell marker, DCLK1, in colon and pancreatic cancer cells: biological impact Cancer Research. 76: 5242-5242
Sarkar S, Connell MO, Popov VL, et al. (2016) Abstract 2957: Generation of a novel, mono-specific, antibody against short Isoform of DCLK1 (DCLK1-S): a novel biomarker of colon carcinogenesis in patients Cancer Research. 76: 2957-2957
O’Connell MR, Sarkar S, Luthra G, et al. (2016) Abstract 2892: FOXD3 is a novel repressor of the expression of short isoform of DCLK1 (DCLK1-S) from IntronV(β)-promoter of hDCLK1-gene, and is epigenetically silenced in hCRCs: prognostic/diagnostic implications of FOXD3/DCLK1-S expression in hCRCs Cancer Research. 76: 2892-2892
Sarkar S, O'Connell MR, Singh P. (2016) Su2058 Curcumin and its Bioavailable Analog (EF24), Differentially Regulate Expression of Long (L) Versus Short (S) Isoforms of DCLK1 in Human Cancer (Colon/Pancreatic) Cells, Dose-Dependently, In Vitro and In Vivo Gastroenterology. 150: S623-S624
See more...